Wilbanks Smith & Thomas Asset Management’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$320K Buy
1,485
+14
+1% +$2.94K 0.01% 424
2023
Q4
$310K Buy
1,471
+128
+10% +$27.3K 0.01% 422
2023
Q3
$269K Buy
+1,343
New +$267K 0.01% 426
2018
Q4
Sell
-202
Closed -$34K 522
2018
Q3
$34K Buy
+202
New +$34K ﹤0.01% 762

Other funds holding CME

Wilbanks Smith & Thomas Asset Management's CME Position: Q1 2024 in Review

Wilbanks Smith & Thomas Asset Management increased its CME Group (CME) stake by 0.95% in Q1 2024, buying an estimated $2.94K and bringing the position to 1,485 shares worth $320K. The position accounts for 0.01% of the portfolio, ranked #424.

Wilbanks Smith & Thomas Asset Management first reported a position in CME in Q3 2018 and has held it in 4 quarters since. 1,374 funds tracked by Wall St. Rank hold CME as of Q1 2024.

  • Wilbanks Smith & Thomas Asset Management held 1,485 shares of CME Group worth $320K as of Q1 2024.
  • Wilbanks Smith & Thomas Asset Management bought 14 CME Group shares in Q1 2024, an estimated $2.94K.
  • CME Group made up 0.01% of Wilbanks Smith & Thomas Asset Management's portfolio in Q1 2024, its #424 holding.
  • Wilbanks Smith & Thomas Asset Management first reported a position in CME Group in Q3 2018 and has held it in 4 quarters since.
  • 1,374 funds tracked by Wall St. Rank held CME Group as of Q1 2024.

Based on Wilbanks Smith & Thomas Asset Management's 13F filing for Q1 2024, filed 7 May 2024.